Hospital Zambrano Hellion pulmonary embolism response team: PERT-PREVENTION

María J. Cabada-García, Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza García, Monterrey, N.L., Mexico
Jaime G. González-Medina, Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza García, Monterrey, N.L., Mexico
Jesús A. Morón-Mosso, Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, San Pedro Garza García, Monterrey, N.L., Mexico
Carlos Jerjes-Sánchez, Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud; Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
José G. Paredes-Vázquez, Medicine and Health Sciences. Tecnológico de Monterrey, Monterrey, Nuevo León, Mexico
Arturo A. Martínez-Ibarra, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
René Gómez, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Alejandro Fabiani, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Erasmo de la Peña-Almaguer, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Juan Quintanilla, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Arturo Cadena, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Vicente Jiménez-Franco, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Jaime A. Guajardo-Lozano, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico
Guillermo Torre-Amione, Institute of Cardiology and Vascular Medicine, TecSalud, Hospital Zambrano Hellion. San Pedro Garza García, Monterrey, N.L., Mexico

Objective: To establish a standardized pulmonary embolism (PE) stratification and diagnosis model while ensuring consistency in response times and therapeutic strategies. Method: In 2019, Mexico’s first PE response team (PERT) was established at Zambrano Hellion Hospital through the Venous Thromboembolism rapid response team (PREVENTION). The program underwent restructuring, drawing on emerging evidence regarding new PTE phenotypes, risk stratification scales, catheter-directed therapies, extracorporeal membrane oxygenation utilization, and the necessity of a collaborative network with the shock team. As a result, the PERT-PREVENTION care protocol was developed, integrating key enhancements to elevate the quality of care. This protocol incorporates advanced strategies to optimize the management of intermediate-risk PE, a category in which selecting the most effective treatment remains a clinical challenge. Results: This approach places the patient at the center of decision-making, promoting a unified, multidisciplinary approach that favors the implementation of individualized strategies based on the best available evidence. Conclusion: The PERT-PREVENTION protocol is designed as a reference model within the institution to refine the identification and application of diagnostic and therapeutic strategies in PE. This approach places the patient at the center of clinical decision-making and renders a unified multidisciplinary framework, enabling the implementation of individualized evidence-based strategies.

Keywords: Pulmonary embolism. Pulmonary embolism response team. PERT. Mexico.